APR, led by its Medicube brand, is expanding its presence in the global market beyond Korea's cosmetics corporations. It rose to No. 3 in market capitalization among pure-play beauty companies worldwide, and its foreign equity stake has steadily increased since the start of the year to the 37% range recently.
APR plans to establish a base for sustained growth by developing its own beauty devices, combining cosmetics and devices in bundled sales, and expanding into medical devices and raw materials, rather than stopping at the temporary success of a single brand.
According to the industry on the 13th, APR posted first-quarter revenue of 593.4 billion won and operating profit of 152.3 billion won this year. Compared with a year earlier, revenue rose 123% and operating profit increased 173.7%. Both revenue and operating profit were the highest ever for a single quarter since the company's founding. In particular, overseas revenue in the first quarter was 528.1 billion won, up 179.9% from a year earlier, and the share of overseas in total revenue climbed to 89%.
In the cosmetics industry, the fourth quarter, when year-end shopping season and large-scale promotions are concentrated, is typically considered the peak season. However, APR surpassed last year's fourth-quarter revenue of 547.6 billion won even in the relatively off-season first quarter. This is interpreted as the result of expanding overseas sales channels and launching new products.
As distribution expansion and overseas performance growth align, there is a clear trend in the capital market of re-evaluating APR. As of the close on the 12th, APR's market capitalization was about 15.55 trillion won, ranking third among global listed companies focused on beauty businesses such as cosmetics and beauty devices. On the same day, No. 1 L'Oreal stood at about 191.5 billion euros (about 335 trillion won), No. 2 Estée Lauder at about $31 billion (about 46 trillion won), and No. 4 Shiseido at about 1.32 trillion yen (about 12.5 trillion won).
Interest from foreign investors is also growing. APR's foreign equity stake, which was around 27% at the start of the year, has recently risen to the 37% range. Compared with the 2–3 percentage point increases in foreign equity stakes at major domestic beauty corporations over the same period, this is a steep climb. As of the previous day's close, Amorepacific's foreign equity stake was 24.7%, and LG H&H's was 27.4%.
APR is focusing on building a base for sustainable growth by establishing a repeat-purchase structure, rather than relying solely on Medicube's short-term popularity. The plan is to move beyond one-off purchases driven by social media (SNS) virality and to cement a long-term revenue base.
In particular, beauty device development capabilities are cited as APR's representative growth driver. Through the Medicube Age-R lineup, APR develops home beauty devices in-house and encourages their use with skincare products such as ampoules, creams, and pads, expanding its product ecosystem.
A beauty industry official said, "Once a device is purchased, the customer maintains contact with the brand for a certain period, and it is highly likely to lead to repeat purchases of related cosmetics," adding, "It is an easier structure to build customer loyalty and repeat revenue than selling single cosmetics."
Expanding the product portfolio is also a pillar of the sustained growth strategy. APR has recently been rolling out functional products that face high global consumer demand, such as PDRN (polydeoxyribonucleotide), collagen, and pore care. Rather than relying on a single hit product, it is broadening lineups by skin concern to expand consumer touchpoints.
According to Shinhan Investment & Securities, the number of APR products within the U.S. Amazon Beauty Top 100 increased from 1–2 in the first quarter of last year to 7–9 in the first quarter of this year. With multiple bestsellers, dependence on a single hit product is decreasing.
APR is expanding its business beyond growth centered on cosmetics and home beauty devices into medical devices and production of the anti-aging new material PN (polynucleotide) raw ingredient. By internalizing technology and production capabilities beyond brand marketing, it plans to reduce performance volatility tied to specific product trends and secure medium- to long-term growth.
Hyung Kwon-hun, an analyst at SK Securities, said, "Much of APR's past growth came from the U.S. online market, which accounts for only about 10% of the global beauty industry," adding, "Given that the share of the U.S. offline and Europe's online-offline markets is around 38%, far larger than online, APR's overseas revenue still has considerable room to grow."